Scribe Therapeutics
Alameda, CA
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
scribetx.comCompany Details
Founded
- 2017
Employees
- Between 50 - 200 employees
Raised
- $120,000,000
Headquarters Location
- Alameda, CA
Public
- No
Acquired
- No
CEO
Benjamin Oakes
Founders
- David F. SavageJennifer DoudnaBrett T StaahlBenjamin Oakes
Company Collections
These are collections Scribe Therapeutics is a part of. Click on the collection name to view similar companies.